NIH staff overseeing dozens of trials on the evolution of corovirus treatment, vaccines and variants on Friday are discussing how to limit or suspend certain studies, estimating that they lack more than $ 1 billion in funding to continue the entire study. Said. In total, the agency will see $ 2.5 billion in spending this year, up to about $ 45 billion in 27 institutions, and may divert funds to meet priorities.
The budget delay comes after Democrats threw away $ 15.6 billion in corporate aid spending from the Omnibus bill earlier this week amid group complaints that their states refused to pay for new aid. During the speaker Nancy Pelosi Promising that new corovarious spending will pass separately, separate legislation has little chance in the Senate, where many lawmakers have questioned past funding for health care agencies.
The $ 15.6 billion allocation was already a significant reduction from the initial $ 30 billion in demand from health officials to continue purchasing Covid-19 vaccines, therapies and tests, as well as conducting research.
NIH and HHS officials did not respond to a request for comment.
Libert warned in his email that senior officials had suggested that there would be no new corovar funding in fiscal year 2023 and that “agencies should be prepared to use basic funding to continue any COVID activities” next year and wrote “new activities should not be funded at this time. That fact must be taken into account. “
The NIH’s core Covid-19 survey, or priority items, cost about $ 700 million, much of it this month, the email said. A large portion of these costs are generated by the accelerated COVID-19 Therapeutic Interventions and Vaccines, or ACTIV, initiative, which includes dozens of trials studying the evolution of antiviral, monoclonal antibodies, vaccines, and variants.
“We especially want to understand the ACTIV trials and the NIH’s plan for these activities if Congress does not provide additional funding (or what is … the final game),” Libert wrote in the email.
Officials warn that if these attempts are reduced, the country will not be equipped to respond to the next wave or the new coronavirus option.
Email: Government Scientists Prepare to Reduce Covid Research Lack of Funding
Source link Email: Government Scientists Prepare to Reduce Covid Research Lack of Funding